New Class of Decoy Molecules that Prevent the Onset of Pain

News   Jan 17, 2018 | Original story from The University of Texas at Dallas

 
New Class of Decoy Molecules that Prevent the Onset of Pain

Dr. Zachary Campbell, who researches pain on the molecular level at the University of Texas at Dallas, recently published a study in the journal Nature Communications that describes a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain. The approach blocks the creation of the proteins that set pain in motion after an injury. Credit: University of Texas at Dallas

 
 
 

RELATED ARTICLES

Neuromodulation of Behavior and Individuality Measured Over a Life-Time

News

Researchers illuminate the biology that guides behavior across different stages of life, and also suggest how variations in specific neuromodulators in the developing nervous system may lead to occasional variations.

READ MORE

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE